Central Nervous System Drugs Market Global Briefing 2017

Published - May 2019| Code - MKB179C| Affiliate - TBRC (Publisher)

Report Highlights

Research Methodology

The report is built on information collected through secondary sources and analysis done by The Business Research Company (TBRC). The secondary sources include the data published by statistical bodies, government agencies, market intelligence databases and annual reports. Insights on the current market scenario, historic and forecast market drivers were gathered from industry reports and news articles.

Note on Market Numbers –

Market value is defined as the revenues earned by organizations for products and services within the specified market. The break down by geography is revenue generated within the specific industry by organizations in the specified geography, irrespective of where they are produced.

North America was the largest region in the central nervous system drugs market worth $43.4 billion in 2018, accounting for 44.5% of the global central nervous system drugs market, followed by Asia Pacific at 23.1% and Western Europe at 20.2% respectively.

Central Nervous System Drugs Global Market Briefing 2019 provides strategists, marketers and senior management with the critical information they need to assess the global central nervous system drugs sector.

Reasons to Purchase

  • Fully updated for 2019.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.

Description

Central Nervous System Drugs Global Market Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the central nervous system drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

The trends and strategies section highlights the likely future developments in the central nervous system drugs market and suggests approaches.

Scope

Markets Covered: Analgesics; Anti-Epileptics; Anesthetics; Anti-Parkinson drugs; Other CNS drugs
Companies Mentioned: Biogen Inc.; Pfizer; Johnson & Johnson; Novartis AG; Sanofi S.A.
Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa
Countries: Australia, China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam, Canada, USA, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, the UK, Czech Republic, Poland, Romania, Russia, Israel, Saudi Arabia, Turkey, UAE, Egypt, Nigeria, South Africa
Time series: Five years historic and forecast
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Central Nervous System Drugs Market, Historic Market Size, 2014-2018
  • Table 2 : Global Central Nervous System Drugs Market, Forecast Market Size, 2018-2022
  • Table 3 : Global Central Nervous System Drugs Market, Split By Segment, 2018
  • Table 4 : Global Central Nervous System Drugs Market, Historic And Forecast, Split By Segment, 2014-2022
  • Table 5 : Global Central Nervous System Drugs Market, Split By Region, 2018
  • Table 6 : Global Central Nervous System Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2014- 2022
  • Figure 1 : Global Central Nervous System Drugs Market, Historic Market Size, 2014-2018
  • Figure 2 : Global Central Nervous System Drugs Market, Forecast Market Size, 2018-2022
  • Figure 3 : Global Central Nervous System Drugs Market, Split By Segment, 2018
  • Figure 4 : Global Central Nervous System Drugs Market, Historic And Forecast, Split By Segment, 2014-2022
  • Figure 5 : Global Central Nervous System Drugs Market, Split By Region, 2018
  • Figure 6 : Global Central Nervous System Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2014-2022

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report